reduce insulin dose when starting glp-1 receptor agonist How Much Do You Take: Dosing Guidelines Explained GLP-1 Receptor Agonists for the
Description
For semaglutide, 25.9% doubled their weight loss, 15.6% had some additional weight loss, and 14.6% maintained their initial loss, totaling 56.1% in the sustained or improved categories

Bkdal TA, Borregaard J, Donsmark M, et al

Some plans cover these medications but only for patients with specific comorbidities like diabetes, heart disease, or sleep apnea
Version 1
Methods: A comprehensive literature search was performed across EMBASE, PubMed, Web of Science, and Google Scholar for studies published from 2014 to 2025

interpreted results of experiments
